Pharma-Bio Serv, Inc.
PBSV
$0.55
$0.07515.79%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.75M | 12.86M | 13.47M | 15.89M | 14.98M |
| Total Receivables | 2.51M | 2.60M | 2.61M | 2.41M | 3.94M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 442.40K | 474.10K | 428.10K | 477.90K | 483.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 15.70M | 15.94M | 16.51M | 18.78M | 19.40M |
|
|
|||||
| Total Current Assets | 15.70M | 15.94M | 16.51M | 18.78M | 19.40M |
| Net Property, Plant & Equipment | 367.90K | 257.40K | 299.90K | 344.50K | 389.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 225.60K | 125.60K | 111.70K | 111.70K | 111.70K |
| Total Assets | 16.29M | 16.32M | 16.92M | 19.23M | 19.90M |
|
|
|||||
| Total Accounts Payable | 1.13M | 1.11M | 1.13M | 1.06M | 1.47M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 165.20K | 161.90K | 158.70K | 155.60K | 152.50K |
| Total Finance Division Other Current Liabilities | 594.30K | 625.00K | 909.90K | 2.46M | 533.80K |
| Total Other Current Liabilities | 594.30K | 625.00K | 909.90K | 2.46M | 533.80K |
| Total Current Liabilities | 1.89M | 1.90M | 2.20M | 3.68M | 2.15M |
|
|
|||||
| Total Current Liabilities | 1.89M | 1.90M | 2.20M | 3.68M | 2.15M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 28.80K | 71.40K | 113.00K | 154.00K | 194.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 660.90K | 660.90K | 660.90K | 1.24M | 1.43M |
| Total Liabilities | 2.58M | 2.63M | 2.97M | 5.07M | 3.78M |
|
|
|||||
| Common Stock & APIC | 1.65M | 1.64M | 1.63M | 1.61M | 1.60M |
| Retained Earnings | 12.35M | 12.34M | 12.65M | 12.86M | 14.85M |
| Treasury Stock & Other | -285.50K | -294.60K | -322.60K | -318.60K | -326.30K |
| Total Common Equity | 13.72M | 13.69M | 13.95M | 14.16M | 16.13M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.72M | 13.69M | 13.95M | 14.16M | 16.13M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.72M | 13.69M | 13.95M | 14.16M | 16.13M |
|
|
|||||
